Pascal Richette

Q: What Schools Are Affiliated With Pascal Richette

Pascal Richette is affiliated with the following schools: Université Paris Cité, Paris Diderot University

Pascal Richette's AcademicInfluence.com Rankings

Pascal Richette

Philosophy

#8502

World Rank

#11897

Historical Rank

Logic

#5533

World Rank

#6940

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Pascal Richette's Degrees

Doctorate Medicine Université Paris Cité
PhD Rheumatology Université Paris Cité

Why Is Pascal Richette Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Pascal Richette's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

2016 updated EULAR evidence-based recommendations for the management of gout (2014) (1029)
Antibodies against polyethylene glycol in healthy subjects and in patients treated with PEG-conjugated agents (2012) (448)
European League Against Rheumatism recommendations for calcium pyrophosphate deposition. Part I: terminology and diagnosis (2011) (399)
Spinal tuberculosis in adults. A study of 103 cases in a developed country, 1980-1994. (1999) (321)
Definition of hyperuricemia and gouty conditions (2014) (289)
MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung Disease (2018) (240)
Benefits of massive weight loss on symptoms, systemic inflammation and cartilage turnover in obese patients with knee osteoarthritis (2010) (220)
Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib (2015) (216)
The DESIR cohort: a 10-year follow-up of early inflammatory back pain in France: study design and baseline characteristics of the 708 recruited patients. (2011) (212)
Impact of comorbidities on gout and hyperuricaemia: an update on prevalence and treatment options (2017) (204)
Biologic agents in osteoarthritis: hopes and disappointments (2013) (200)
Efficacy of rituximab in systemic manifestations of primary Sjögren's syndrome: results in 78 patients of the AutoImmune and Rituximab registry (2012) (195)
Effect of anakinra versus usual care in adults in hospital with COVID-19 and mild-to-moderate pneumonia (CORIMUNO-ANA-1): a randomised controlled trial (2021) (195)
Systemic inhibition of IL-6/Stat3 signalling protects against experimental osteoarthritis (2016) (191)
EULAR recommendations for calcium pyrophosphate deposition. Part II: Management (2011) (184)
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout (2019) (167)
An update on the epidemiology of calcium pyrophosphate dihydrate crystal deposition disease. (2009) (165)
Improving cardiovascular and renal outcomes in gout: what should we target? (2014) (163)
Estrogens, cartilage, and osteoarthritis. (2003) (163)
Diabetes is a risk factor for knee osteoarthritis progression. (2015) (151)
Gout (1975) (146)
Consensus statement on viscosupplementation with hyaluronic acid for the management of osteoarthritis. (2015) (145)
Emerging pharmaceutical therapies for osteoarthritis (2020) (133)
Impact of a nurse-led programme on comorbidity management and impact of a patient self-assessment of disease activity on the management of rheumatoid arthritis: results of a prospective, multicentre, randomised, controlled trial (COMEDRA) (2014) (129)
Adalimumab in patients with hand osteoarthritis refractory to analgesics and NSAIDs: a randomised, multicentre, double-blind, placebo-controlled trial (2014) (127)
Revisiting comorbidities in gout: a cluster analysis (2013) (124)
Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis (2017) (123)
Effect of hyaluronic acid in symptomatic hip osteoarthritis: a multicenter, randomized, placebo-controlled trial. (2009) (111)
Efficacy of anakinra in gouty arthritis: a retrospective study of 40 cases (2013) (102)
Hidradenitis Suppurativa Associated with Spondyloarthritis — Results from a Multicenter National Prospective Study (2014) (101)
Rasburicase for tophaceous gout not treatable with allopurinol: an exploratory study. (2007) (93)
Impact of allopurinol on risk of myocardial infarction (2014) (92)
Splint for Base-of-Thumb Osteoarthritis (2009) (89)
Use of Intraarticular Hyaluronic Acid in the Management of Knee Osteoarthritis in Clinical Practice (2017) (88)
Clinical presentation of patients suffering from recent onset chronic inflammatory back pain suggestive of spondyloarthritis: The DESIR cohort. (2015) (87)
Achondroplasia: from genotype to phenotype. (2008) (86)
Rituximab therapy for systemic vasculitis associated with rheumatoid arthritis: Results from the Autoimmunity and Rituximab Registry (2012) (83)
Interaction of HIF1α and β-catenin inhibits matrix metalloproteinase 13 expression and prevents cartilage damage in mice (2016) (81)
Methotrexate and rheumatoid arthritis associated interstitial lung disease (2020) (79)
Uric acid and incident dementia over 12 years of follow-up: a population-based cohort study (2017) (79)
Does platelet-rich plasma have a role in the treatment of osteoarthritis? (2016) (79)
Sensory neuropathy revealing necrotizing vasculitis during infliximab therapy for rheumatoid arthritis. (2004) (76)
Ultrasonography in gout: a case-control study. (2012) (75)
Hyaluronan for knee osteoarthritis: an updated meta-analysis of trials with low risk of bias (2015) (75)
Cyclic tensile stretch modulates proteoglycan production by intervertebral disc annulus fibrosus cells through production of nitrite oxide (2003) (74)
Usefulness of ultrasonography for gout. (2012) (73)
Causal Factors for Knee, Hip, and Hand Osteoarthritis: A Mendelian Randomization Study in the UK Biobank (2019) (72)
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis (2015) (70)
TNF alpha antagonist therapy and safety monitoring. (2011) (68)
Prevalence of Gout in the Adult Population of France (2016) (67)
Discordant American College of Physicians and international rheumatology guidelines for gout management: consensus statement of the Gout, Hyperuricemia and Crystal-Associated Disease Network (G-CAN) (2017) (65)
Comparing patient-perceived and physician-perceived remission and low disease activity in psoriatic arthritis: an analysis of 410 patients from 14 countries (2018) (60)
Musculoskeletal Complications of Hereditary Hemochromatosis: A Case-Control Study (2010) (59)
Gout, Hyperuricemia, and Crystal‐Associated Disease Network Consensus Statement Regarding Labels and Definitions for Disease Elements in Gout (2019) (59)
Early decrease of serum biomarkers of type II collagen degradation (Coll2‐1) and joint inflammation (Coll2‐1 NO2) by hyaluronic acid intra‐articular injections in patients with knee osteoarthritis: A research study part of the Biovisco study (2013) (58)
Peroxisome Proliferator-activated Receptor-γ Down-regulates Chondrocyte Matrix Metalloproteinase-1 via a Novel Composite Element* (2004) (57)
The ANKH gene and familial calcium pyrophosphate dihydrate deposition disease. (2004) (54)
[Epidemiological aspects of osteoarticular tuberculosis in adults. Retrospective study of 206 cases diagnosed in the Paris area from 1980 to 1994]. (1997) (53)
Safety and efficacy of paracetamol and NSAIDs in osteoarthritis: which drug to recommend? (2015) (51)
Disease activity is longitudinally related to sacroiliac inflammation on MRI in male patients with axial spondyloarthritis: 2-years of the DESIR cohort (2015) (50)
An exploratory ultrasound study of early gout. (2011) (50)
Dual effects of 17β-oestradiol on interleukin 1β-induced proteoglycan degradation in chondrocytes (2004) (50)
Hypomagnesemia associated with chondrocalcinosis: a cross-sectional study. (2007) (50)
Gout, Hyperuricaemia and Crystal-Associated Disease Network (G-CAN) consensus statement regarding labels and definitions of disease states of gout (2019) (49)
Therapeutic perspectives on uricases for gout. (2012) (48)
Treatment of carpal tunnel syndrome : from ultrasonography to ultrasound guided carpal tunnel release. (2017) (47)
International position paper on febuxostat (2010) (47)
A high interleukin 1 receptor antagonist/IL-1beta ratio occurs naturally in knee osteoarthritis. (2008) (45)
Paradoxical adverse effects of anti-TNF-α treatment: onset or exacerbation of cutaneous disorders (2009) (45)
Recommendations for an update of the 2010 European regulatory guideline on clinical investigation of medicinal products used in the treatment of osteoarthritis and reflections about related clinically relevant outcomes: expert consensus statement. (2015) (45)
Early effect of hyaluronic acid intra‐articular injections on serum and urine biomarkers in patients with knee osteoarthritis: An open‐label observational prospective study (2012) (45)
Activation of the peroxisome proliferator-activated receptor alpha pathway potentiates interleukin-1 receptor antagonist production in cytokine-treated chondrocytes. (2006) (44)
Iron overload in a murine model of hereditary hemochromatosis is associated with accelerated progression of osteoarthritis under mechanical stress. (2016) (43)
Successful treatment with rasburicase of a tophaceous gout in a patient allergic to allopurinol (2006) (43)
Assessment of dynamic humeral centering in shoulder pain with impingement syndrome: a randomised clinical trial (2011) (42)
Colchicine for the treatment of gout (2010) (42)
Efficacy of tocilizumab in patients with hand osteoarthritis: double blind, randomised, placebo-controlled, multicentre trial (2020) (41)
Importance of synovitis in osteoarthritis: evidence for the use of glycosaminoglycans against synovial inflammation. (2014) (40)
Psoriasis induced by anti-tumor necrosis factor therapy: a class effect? (2007) (40)
Emergence of severe spondyloarthropathy-related entheseal pathology following successful vedolizumab therapy for inflammatory bowel disease. (2018) (40)
Prophylaxis for acute gout flares after initiation of urate-lowering therapy. (2014) (40)
Current and future therapies for gout (2017) (39)
Prevalence of generalized osteoarthritis in a population with knee osteoarthritis. (2011) (38)
Efficacy of anakinra for refractory acute calcium pyrophosphate crystal arthritis. (2012) (38)
Weight Loss, Xanthine Oxidase, and Serum Urate Levels: A Prospective Longitudinal Study of Obese Patients (2016) (38)
Spinal involvement with calcium pyrophosphate deposition disease in an academic rheumatology center: A series of 37 patients. (2019) (38)
Oestrogens inhibit interleukin 1β-mediated nitric oxide synthase expression in articular chondrocytes through nuclear factor-κB impairment (2006) (37)
Desperately looking for the right target in osteoarthritis: the anti-IL-1 strategy (2011) (37)
Gout and pseudo-gout-related crystals promote GLUT1-mediated glycolysis that governs NLRP3 and interleukin-1β activation on macrophages (2020) (36)
Efficacy and safety of febuxostat in 73 gouty patients with stage 4/5 chronic kidney disease: A retrospective study of 10 centers. (2017) (36)
Failure to reach uric acid target of <0.36 mmol/L in hyperuricaemia of gout is associated with elevated total and cardiovascular mortality (2019) (35)
EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis (2018) (34)
Investigational drugs for hyperuricemia, an update on recent developments (2018) (33)
Colchicine in Gout: An Update. (2018) (33)
Hypomagnesemia and chondrocalcinosis in short bowel syndrome. (2005) (32)
Cardiac and renal protective effects of urate-lowering therapy (2018) (31)
Structure-modifying agents for osteoarthritis: an update. (2004) (31)
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty (2015) (31)
Onset of psoriatic arthritis in patients treated with efalizumab for moderate to severe psoriasis. (2008) (31)
Anterior Chest Wall Pain in Recent Inflammatory Back Pain Suggestive of Spondyloarthritis. Data from the DESIR Cohort (2013) (29)
A cross sectional study of 502 patients found a diffuse hyperechoic kidney medulla pattern in patients with severe gout. (2020) (29)
Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis (2017) (29)
Determinants of Patient‐Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen Countries (2020) (28)
Nonsurgical treatment of osteoarticular tuberculosis. A retrospective study in 143 adults. (1999) (28)
Decision Algorithms for the Retreatment with Viscosupplementation in Patients Suffering from Knee Osteoarthritis: Recommendations from the EUROpean VIScosupplementation COnsensus Group (EUROVISCO) (2018) (28)
Psoriasis and phenotype of patients with early inflammatory back pain (2012) (28)
Efficacy of intralesional sodium thiosulfate injections for disabling tumoral calcinosis: Two cases. (2017) (28)
Efficacy of joint lavage in knee osteoarthritis: meta-analysis of randomized controlled studies. (2010) (28)
Ultrasound evaluation in follow-up of urate-lowering therapy in gout: the USEFUL study (2018) (28)
Uric acid and cognitive decline: a double-edge sword? (2017) (27)
Does platelet-rich plasma deserve a role in the treatment of tendinopathy? (2015) (27)
Identification of patients with gout: elaboration of a questionnaire for epidemiological studies (2014) (27)
Effectiveness and safety of anakinra in gout patients with stage 4-5 chronic kidney disease or kidney transplantation: A multicentre, retrospective study. (2018) (27)
Reduction of the Serum Levels of a Specific Biomarker of Cartilage Degradation (Coll2-1) by Hyaluronic Acid (KARTILAGE® CROSS) Compared to Placebo in Painful Knee Osteoarthritis Patients: the EPIKART Study, a Pilot Prospective Comparative Randomized Double Blind Trial (2017) (26)
SAT0532 Updated Eular Evidence-Based Recommendations for the Diagnosis of Gout (2014) (26)
Serum uric acid and metabolic risk (2013) (26)
Efficacy of a functional restoration program for chronic low back pain: prospective 1-year study. (2010) (26)
Dual effects of 17beta-oestradiol on interleukin 1beta-induced proteoglycan degradation in chondrocytes. (2004) (25)
Intra-articular injections of platelet-rich plasma in symptomatic knee osteoarthritis: a consensus statement from French-speaking experts (2020) (24)
Statin use and knee osteoarthritis progression: Results from a post-hoc analysis of the SEKOIA trial. (2017) (24)
Sarilumab in adults hospitalised with moderate-to-severe COVID-19 pneumonia (CORIMUNO-SARI-1): An open-label randomised controlled trial (2021) (24)
2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy. (2020) (24)
Recommendations of the French Society of Rheumatology on pharmacological treatment of knee osteoarthritis. (2020) (24)
PAPASH, PsAPASH and PASS autoinflammatory syndromes: phenotypic heterogeneity, common biological signature and response to immunosuppressive regimens (2019) (24)
Intravenous sodium thiosulfate for treating tumoral calcinosis associated with systemic disorders: Report of four cases. (2017) (23)
Role of dual-energy CT in the diagnosis and follow-up of gout: systematic analysis of the literature (2018) (23)
Current management of gout: practical messages from 2016 EULAR guidelines. (2017) (23)
Abatacept therapy and safety management. (2012) (23)
Purine-rich foods: an innocent bystander of gout attacks? (2012) (22)
Comparison of general practitioners and rheumatologists' prescription patterns for patients with knee osteoarthritis (2011) (22)
Clinically meaningful effect of strontium ranelate on symptoms in knee osteoarthritis: a responder analysis. (2014) (22)
Natural chondroitin sulphates increase aggregation of proteoglycan complexes and decrease adamts-5 expression in interleukin 1β-treated chondrocytes (2007) (21)
MRI and serum biomarkers correlate with radiographic features in painful hand osteoarthritis. (2016) (20)
Anti-Saccharomyces cerevisiae Immunogloblin G and Immunoglobulin A antibodies are associated with systemic inflammation and advanced disease in hidradenitis suppurativa. (2020) (20)
Characteristics and management of gout patients in Europe: data from a large cohort of patients. (2015) (20)
Nephrogenic systemic fibrosis (2010) (19)
Efficacy and safety of lesinurad for the treatment of hyperuricemia in gout (2019) (19)
Hes1, a new target for interleukin 1β in chondrocytes (2009) (19)
Hyaluronan derivative HYMOVIS® increases cartilage volume and type ii collagen turnover in osteoarhritic knee: data from MOKHA study (2018) (19)
Oestrogens inhibit interleukin 1beta-mediated nitric oxide synthase expression in articular chondrocytes through nuclear factor-kappa B impairment. (2007) (19)
Should prednisolone be first-line therapy for acute gout? (2008) (18)
Manifestations cutanées paradoxales des anti-TNF-alpha (2010) (18)
SAT0531 Updated Eular Evidence-Based Recommendations for the Management of Gout (2014) (17)
The management of hyperuricemia with urate deposition (2015) (17)
Increase in type II collagen turnover after iron depletion in patients with hereditary haemochromatosis. (2010) (16)
Safety of surgery in patients with rheumatoid arthritis treated by abatacept: data from the French Orencia in Rheumatoid Arthritis Registry (2017) (15)
Bone mineral density in patients with rapidly destructive or common hip osteoarthritis. (2009) (15)
Renal medulla in severe gout: typical findings on ultrasonography and dual-energy CT study in two patients (2018) (15)
Traduction française des recommandations de l’Osteoarthritis Research Society International (OARSI) sur la prise en charge de la gonarthrose et de la coxarthrose (2009) (15)
Crystal arthritis: New ACR guidelines for gout management hold some surprises (2013) (14)
The learning curve of nurses for the assessment of swollen and tender joints in rheumatoid arthritis. (2014) (14)
Incidence Rates of Interstitial Lung Disease Events in Tofacitinib-Treated Rheumatoid Arthritis Patients (2020) (14)
The DIGICOD cohort: a hospital-based observational prospective cohort of patients with hand osteoarthritis - methodology and baseline characteristics of the population. (2021) (14)
Postoperative spondylodiscitis due to Kytococcus schroeteri in a diabetic woman. (2010) (14)
Evaluation of the performances of ‘typical’ imaging abnormalities of axial spondyloarthritis: results of the cross-sectional ILOS-DESIR study (2019) (14)
Novel uricosurics (2018) (13)
EUROVISCO Guidelines for the Design and Conduct of Clinical Trials Assessing the Disease-Modifying Effect of Knee Viscosupplementation (2018) (13)
The role of febuxostat in gout (2019) (13)
Septic arthritis of the hip with psoas abscess caused by Non-typhi Salmonella infection in an immunocompetent patient. (2008) (13)
Accuracy of the HumaSensplus point-of-care uric acid meter using capillary blood obtained by fingertip puncture (2018) (13)
Proprotein convertase furin inhibits matrix metalloproteinase 13 in a TGFβ-dependent manner and limits osteoarthritis in mice (2018) (13)
International position paper on the appropriate use of uricosurics with the introduction of lesinurad (2018) (13)
Results of a global, patient-based survey assessing the impact of psoriatic arthritis discussed in the context of the Psoriatic Arthritis Impact of Disease (PsAID) questionnaire (2020) (13)
Modulation of proteoglycan production by cyclic tensile stretch in intervertebral disc cells through a post-translational mechanism. (2006) (12)
Neutrophilic cholangitis in psoriasis vulgaris and psoriatic arthritis (2013) (12)
Coccydynia Related to Calcium Crystal Deposition (2008) (12)
Premature enthusiasm for the use of methotrexate for refractory chondrocalcinosis: comment on the article by Chollet-Janin et al. (2008) (12)
Cartilage articulaire normal : anatomie, physiologie, métabolisme, vieillissement (2006) (12)
Risk factors for cutaneous reactions to allopurinol in Kinh Vietnamese: results from a case-control study (2020) (12)
Identifying Potential Classification Criteria for Calcium Pyrophosphate Deposition Disease: Item Generation and Item Reduction (2021) (12)
Improving agreement in assessment of synovitis in rheumatoid arthritis. (2013) (12)
Pharmacokinetics considerations for gout treatments (2014) (12)
La coxarthrose destructrice rapide (2009) (11)
[Management of osteoarthritis: oral therapies]. (2012) (11)
Impact of treatments for osteoporosis on cartilage biomarkers in humans (2012) (11)
Costs of early spondyloarthritis: estimates from the first 3 years of the DESIR cohort (2016) (11)
Interleukin-1 receptor antagonist in refractory haemochromatosis-related arthritis of the hands (2013) (11)
OARSI ) recommendations for the management of knee and hip osteoarthritis (2009) (11)
Usefulness of taping in lower limb osteoarthritis. French clinical practice guidelines. (2008) (11)
How safe is acetaminophen in rheumatology? (2014) (10)
Low incidence of vertebral fractures in early spondyloarthritis: 5-year prospective data of the DESIR cohort (2017) (10)
Evaluation of the impact of a nurse-led program of patient self-assessment and self-management in axial spondyloarthritis: results of a prospective, multicentre, randomized, controlled trial (COMEDSPA). (2020) (10)
Impact of anti-inflammatory therapies, xanthine oxidase inhibitors and other urate-lowering therapies on cardiovascular diseases in gout (2015) (10)
Arthritis secondary to meningococcal disease (2017) (10)
International position paper on febuxostat (2010) (10)
Effectiveness of IL-12/23 inhibition (ustekinumab) versus tumour necrosis factor inhibition in psoriatic arthritis: observational PsABio study results (2021) (10)
Hyaluronic acid: Still useful in knee osteoarthritis? (2017) (10)
Treatment of Nongout Joint Deposition Diseases: An Update (2014) (10)
Inhibition of sphingosine 1-phosphate protects mice against chondrocyte catabolism and osteoarthritis. (2021) (9)
Épidémiologie et génétique de la goutte (2011) (9)
2020 Recommendations from the French Society of Rheumatology for the management of gout: management of acute flares. (2020) (9)
Impact of treatments for osteoporosis on osteoarthritis progression (2012) (9)
FAST: new look at the febuxostat safety profile (2020) (9)
Traitement médical de la tuberculose ostéo-articulaire : Etude rétrospective de 143 cas chez l'adulte (1999) (9)
Chondrocalcinosis of the Knee and the Risk of Osteoarthritis Progression: Data From the Knee and Hip Osteoarthritis Long‐term Assessment Cohort (2020) (9)
Association of Specific Comorbidities with Monosodium Urate Crystal Deposition in Urate-Lowering Therapy-Naive Gout Patients: A Cross-Sectional Dual-Energy Computed Tomography Study (2020) (9)
Cost utility modeling of early vs late total knee replacement in osteoarthritis patients. (2016) (9)
Benefits of Polymerase Chain Reaction Combined With Culture for the Diagnosis of Bone and Joint Infections: A Prospective Test Performance Study (2019) (9)
[Paradoxical cutaneous manifestations during anti-TNF-alpha therapy]. (2010) (9)
a randomized, multicentre, double blind, placebo-controlled trial of anti TNF alpha (adalimumab) in refractory hand osteoarthritis. The Dora study (2013) (9)
Ultrasound-Guided Surgery for Carpal Tunnel Syndrome: A New Interventional Procedure (2018) (9)
Computational Lexical Analysis of the Language Commonly Used to Describe Gout (2016) (8)
Nouveaux traitements de la goutte (2011) (8)
[Calcium pyrophosphate deposition disease]. (2011) (8)
Online Training on Skin Cancer Diagnosis in Rheumatologists: Results from a Nationwide Randomized Web-Based Survey (2015) (8)
Evaluation of the impact of a nurse-led program of systematic screening of comorbidities in patients with axial spondyloarthritis: The results of the COMEDSPA prospective, controlled, one year randomized trial. (2020) (8)
2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis. (2022) (8)
[Basic calcium phosphate crystal deposition disease]. (2011) (8)
Coexisting pseudo-xanthoma elasticum and rheumatoid arthritis. three cases and review of the literature. (2001) (8)
Dyslipidemia, Alcohol Consumption, and Obesity as Main Factors Associated With Poor Control of Urate Levels in Patients Receiving Urate‐Lowering Therapy (2018) (8)
Screening for and management of comorbidities after a nurse-led program: results of a 3-year longitudinal study in 769 established rheumatoid arthritis patients (2019) (8)
Do Glucocorticoid Injections Increase the Risk of Knee Osteoarthritis Progression Over 5 Years? (2022) (8)
Effect of C282Y Genotype on Self-Reported Musculoskeletal Complications in Hereditary Hemochromatosis (2015) (8)
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparison. (2020) (7)
A 12-point recommendation framework to support advancement of the multidisciplinary care of psoriatic arthritis: A call to action. (2021) (7)
Le risque tuberculeux persiste chez les patients traités par anti-TNFa. Identification des facteurs de risque chez ces patients (2006) (7)
Pain in women with knee and/or hip osteoarthritis is related to systemic inflammation and to adipose tissue dysfunction: Cross-sectional results of the KHOALA cohort. (2020) (7)
SAT0544 Prevalence of Gout in the Adult Population of France in 2013 (2014) (7)
Efficacité d’un programme de restauration fonctionnelle pour lombalgie chronique : étude prospective sur un an ☆ (2010) (7)
Correlation between serum and synovial fluid estrogen concentrations: comment on the article by Sowers et al. (2007) (7)
Généralités sur l'arthrose : épidémiologie et facteurs de risque (2008) (7)
Muscle magnetic resonance imaging sensitivity does not decrease in chronic, mild, or proximal lower limb neuropathies (2012) (7)
Hyperuricemia, Gout, and the Brain—an Update (2021) (7)
Critical appraisal of the role of pegloticase in the management of gout. (2012) (6)
Whipple disease mimicking adult-onset Still’s disease and treated by anakinra: diagnosis using PCR (2012) (6)
Reproducibility of sub-acromial impingement tests, including a new clinical manoeuver. (2018) (6)
Rheumatic manifestations of renal disease (2009) (6)
Early decrease of serum biomarkers of type II collagen degradation (Coll2-1) and joint inflammation (Coll2-1NO2) by hyaluronic acid intra-articular injections in patients with knee osteoarthritis (2011) (6)
Calcium Pyrophosphate Dihydrate Crystal Deposition in Gouty Tophi (2020) (6)
Novel drug discovery strategies for gout (2013) (6)
Obésité, hyperuricémie et goutte (2016) (5)
Intérêt de l’échographie dans la goutte (2012) (5)
OP0284 Impact of a Nurse Led Program of Patient Self-Assessment of Disease Activity on the Management of Rheumatoid Arthritis: Results of a Prospective, Multicentre, Randomized, Controlled Trial (Comedra) (2013) (5)
Chondrocalcinosis of the knee and the risk for osteoarthritis progression: data from the KHOALA cohort. (2019) (5)
Diagnostic criteria for generalized osteoarthritis: a preliminary study in a population with knee osteoarthritis. (2011) (5)
Tocilizumab in symptomatic calcium pyrophosphate deposition disease: a pilot study (2020) (5)
A definite case of spondylodiscitis caused by Streptococcus equisimilis. (2001) (5)
Response: Renal dosing of allopurinol results in suboptimal gout care by T Neogi et al (2016) (5)
La coxarthrose destructrice rapide revisitée (2004) (5)
In patients with axial spondyloarthritis, inflammation on MRI of the spine is longitudinally related to disease activity only in men: 2 years of the axial spondyloarthritis DESIR cohort (2017) (5)
UltraSound Evaluation in Follow-up of Urate-Lowering therapy in gout phase 2 (USEFUL-2): duration of flare prophylaxis. (2020) (5)
[Pharmacological therapies for osteoarthritis]. (2011) (5)
Debulking the Urate Load to Feel Better (2012) (5)
Approches thérapeutiques de l’arthrose (2011) (5)
Measurable definitions of ankylosing spondylitis management recommendations are needed for use in observational studies. (2016) (5)
High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame? (2020) (5)
Quelle place pour les PRP (plasma riche en plaquettes) dans l’arthrose ? (2014) (5)
Effect of Prehabilitation Before Total Knee Replacement for Knee Osteoarthritis on Functional Outcomes (2022) (5)
THU0463 Epidemiology of gout and hyperuricemia in new caledonia (2017) (5)
AB0007 Shared genetic predisposition in rheumatoid arthritis–interstitial lung disease and familial pulmonary fibrosis (2017) (5)
Recommandations 2020 de la Société française de rhumatologie pour la prise en charge de la goutte : traitement des crises de goutte (2020) (4)
IL-6/STAT3 signalling blockade protects against experimental osteoarthritis in mice (2016) (4)
Prevalence and consequences of psoriasis in recent axial spondyloarthritis: an analysis of the DESIR cohort over 6 years (2022) (4)
[The epidemiology and genetic of gout]. (2011) (4)
Goutte : mise en place et suivi du traitement hypo-uricémiant (2011) (4)
Response to: ‘Uric acid and incident dementia: a population-based cohort study’ by Lee and Song (2017) (4)
Is self-assessment by patients of disease activity acceptable over the long term in rheumatoid arthritis? A 3-year follow-up of 771 patients. (2019) (4)
Lin28a induces SOX9 and chondrocyte reprogramming via HMGA2 and blunts cartilage loss in mice (2022) (4)
Calcium Pyrophosphate Crystal Deposition in a Cohort of 57 Patients with Gitelman Syndrome. (2021) (4)
SUA levels should not be maintained <3 mg/dL for several years. Response to ‘EULAR gout treatment guidelines by Richette et al: uric acid and neurocognition by Singh et al’ (2017) (4)
Aspergillus-related myositis: a case report and review of the literature. (2011) (4)
L’achondroplasie : du génotype au phénotype ☆ (2008) (4)
SAT0427 Multicentric Osteoarthritis Intervention Study with Sysadoa (MOVES): Effects of Combined Glucosamine Hydrochloride and Chondroitin Sulfate VS Celecoxib for Painful Knee Osteoarthritis (2014) (4)
Recommandations de la Société française de rhumatologie pour la prise en charge de la goutte : le traitement hypo-uricémiant (2020) (4)
Viscosupplementation for the treatment of osteoarthritis. The contribution of EUROVISCO group (2021) (4)
Upadacitinib as monotherapy and in combination with non-biologic disease-modifying antirheumatic drugs for psoriatic arthritis (2021) (4)
Reassessing the Safety Profile of Lesinurad in Combination with Xanthine Oxidase Inhibitor Therapy (2019) (4)
[Osteoarthritis: value of imaging and biomarkers]. (2019) (4)
005 BENEFITS OF MASSIVE WEIGHT LOSS ON SYMPTOMS, SYSTEMIC INFLAMMATION AND CARTILAGE TURNOVER IN OBESE PATIENTSWITH KNEE OSTEOARTHRITIS (2010) (3)
OP0234 Impact of a Nurse Led Program on the Management of Comorbidities in Rheumatoid Arthritis (RA). Results of a Prospective, Multicentre, Randomized, Controlled Trial (Comedra) (2013) (3)
Iterative percutaneous needle aponeurotomy for Dupuytren's disease: functional outcome at 5-year follow-up. (2020) (3)
[New therapeutic options for gout]. (2011) (3)
Efficacité et tolérance de la Rasburicase (Fasturtec®) chez des patients goutteux intolérants ou réfractaires à l'allopurinol (2006) (3)
Recommandations de la Société française de rhumatologie sur la prise en charge pharmacologique de la gonarthrose (2020) (3)
Les traitements hypo-uricémiants disponibles dans la goutte (2012) (3)
505 EFFECTS OF JOINT LAVAGE IN PATIENTS WITH OSTEOARTHRITIS OF THE KNEE: META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS (2008) (3)
Viscosupplémentation au genou (2016) (3)
OP0054 Incidence of vertebral fractures in early spondyloarthritis: 5-year prospective data of the desir cohort (2017) (3)
SAT0035 Chondroprotective Effects of IL-6 Inhibition Through Blockade of the STAT3 Pathway (2015) (3)
Shoulder adhesive capsulitis: diagnostic value of active and passive range of motion with volume of gleno-humeral capsule as a reference. (2019) (3)
Chirurgie bariatrique et rhumatologie (2016) (3)
Onset of comorbidities and flare patterns within pre-existing morbidity clusters in people with gout: 5-year primary care cohort study. (2021) (3)
[Gout: an overview of available urate lowering therapies]. (2012) (3)
Erratum to: Effect of music on anxiety and pain during joint lavage for knee osteoarthritis (2012) (3)
ESTROGENS INHIBIT INTERLEUKIN-1β-MEDIATED NITRIC OXIDE SYNTHASE EXPRESSION IN ARTICULAR CHONDROCYTES THROUGH NF-κB IMPAIRMENT (2007) (3)
Effect of hyaluronic acid in symptomatic hip osteoarthritis: A multicentre, randomised, double-blind, placebo-controlled study (2008) (3)
ACR (2020) (3)
How do clinical and socioeconomic factors impact on work disability in early axial spondyloarthritis? Five-year data from the DESIR cohort (2021) (3)
Inhibition of ADAMTS-5: the right target for osteoarthritis? (2021) (2)
Œstrogènes, cartilage et arthrose (2003) (2)
Treatment of Trigger Finger by Ultrasound-Guided Needle Release of A1 Pulley: A Series of 105 Cases. (2022) (2)
Do corticosteroids or hyaluronic acid intra-articular injections impact the risk of total knee replacement? Real-life data from the khoala cohort (2019) (2)
Combined chondroitin sulfate and Glucosamine versus celecoxib for painful Knee osteoarthritis: post-hoc analyses by Kellgren and Lawrence grade and C-reactive protein level from a randomized, double-blind, multicentre clinical trial (2015) (2)
Correction to: Intra‑articular injections of platelet‑rich plasma in symptomatic knee osteoarthritis: a consensus statement from French‑speaking experts (2020) (2)
THU0237 Inflammatory lesions of the sacroiliac joints, but not of the spine, are of high utility for axspa recognition: results of the ilos-desir study (2018) (2)
Efficacité de l’éducation thérapeutique (ETP) dans la goutte : résultats sur 80 patients (2016) (2)
Patient Perceptions of Psoriatic Arthritis Management and Communication with Physicians in Australia: Results from a Patient Survey (2021) (2)
Hemarthrosis: an unusual complication of type 1 neurofibromatosis. (2001) (2)
Can gout management guidelines be solely evidence based? (2020) (2)
Biothérapies en développement dans l’arthrose (2011) (2)
531 EFFECT OF HYALURONIC ACID IN SYMPTOMATIC HIP OA: A MULTICENTRE, RANDOMISED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY (2008) (2)
Obésité et goutte (2015) (2)
Health claims assessment in the field of joint and cartilage: a consensus viewpoint of the Group for the Respect of Ethics and Excellence in Science (2012) (2)
Exploring the Quality of Communication Between Patients with Psoriatic Arthritis and Physicians: Results of a Global Online Survey (2021) (2)
Access criteria for anti-TNF agents in spondyloarthritis: influence on comparative 1-year cost-effectiveness estimates (2017) (2)
Présentation clinique des patients souffrant de rachialgie inflammatoire chronique récente évocatrice de spondyloarthrite : la cohorte Desir (2015) (2)
Hyperferritinaemia and hyperuricaemia — a causal connection? (2018) (2)
Fat mass and response to TNFα blockers in early axial spondyloarthritis: an analysis of the DESIR cohort (2021) (2)
[Obesity and knee osteoarthritis]. (2007) (2)
Perspectives des uricases dans la goutte (2012) (2)
Recommendations of the French society of rheumatology for the pharmacological management of knee osteoarthritis (2019) (2)
OP0052 FAILURE TO REACH SERUM URATE TARGET IS ASSOCIATED WITH ELEVATED MORTALITY IN GOUT (2019) (2)
The shrinking toe sign in gout. (2022) (1)
Impact of components of the metabolic syndrome on knee osteoarthritis progression in the SEKOIA study (2014) (1)
144 EARLY DECREASE OF SERUM BIOMARKERS OF TYPE II COLLAGEN DEGRADATION (Coll2-l) AND JOINT INFLAMMATION (Coll2-lN02) BY HYALURONIC ACID INTRA-ARTICULAR INJECTIONS IN PATIENTS WITH KNEE OSTEOARTHRITIS (2011) (1)
Periostitis in a Patient with Inflammatory Bowel Disease (2012) (1)
OP0189 Identification of new and rare variants in abcg2, slc22a1 and aldh16a1 genes in crystal-proven early-onset gout (2018) (1)
OP0357 Hyperechoic deposits in the renal medulla are associated with severe gout and decreased egfr: a transversal study in 503 vietnamese patients (2018) (1)
Response to ‘Everything we see is a perspective, not the truth’ by Chattopadhyay et al (2019) (1)
Reflections on the American College of Rheumatology recommendations for osteoarthritis from the French Section on Osteoarthritis: Comment on the article by Hochberg et al (2013) (1)
FRI0371 Characteristics of gout patients in france: The “cactus” study (2013) (1)
AB0760 DRUG SURVIVAL AND EFFICACY OF USTEKINUMAB AND SECUKINUMAB IN PSORIATIC ARTHRITIS: A REAL-WORLD MULTICENTRIC COHORT OF 186 PATIENTS (2019) (1)
Iterative percutaneous needle aponeurotomy for Dupuytren's disease: Functional results at 5-year follow-up (2018) (1)
FRI0140 Developing Quality Criteria from the Assessments in Ankylosing Spondylitis Society (ASAS) and European League against Rheumatism (EULAR) Ankylosing Spondylitis Management Recommendations: towards Quantitative Definitions of “Non-Compliance” (2014) (1)
SAT0418 The Serum Leptin/Adiponectin Ratio, A Useful Estimate of Insulin Resistance, is Associated with Clinical Symptoms in Hip Osteoarthritis: Results of the Population-Based French Khoala Cohort (2014) (1)
Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations (2022) (1)
Adherence to Antitumor Necrosis Factor Use Recommendations in Spondyloarthritis: Measurement and Effect in the DESIR Cohort (2017) (1)
DIGICOD, 1ère cohorte française de patients souffrant d’arthrose digitale : méthodologie et description de la population d’inclusion (2020) (1)
432 INTER- AND INTRA-OBSERVER REPRODUCIBILITY OF THE RADIOGRAPHIC KELLGREN-LAWRENCE SCORING SYSTEM IN HAND OSTEOARTHRITIS (HOA) (2009) (1)
Inhibition of the interleukin-6-induced STAT3 signalling pathway is chondroprotective (2015) (1)
POS0238 SICK LEAVE AND ITS PREDICTORS IN EARLY AXIAL SPONDYLOARTHRITIS: THE ROLE OF CLINICAL AND SOCIOECONOMIC FACTORS. FIVE-YEAR DATA FROM THE DESIR COHORT (2021) (1)
Distribution of bony erosions in feet and performance of two bone erosion scores: A dual-energy computed tomography study of 61 patients with gout (2021) (1)
Peroxisome proliferator-activated receptor gamma and its ligands in controlling interleukin-1beta target gene expression: a confusing story. (2005) (1)
Spine abnormalities associated with bone edema on sacroiliac joints MRI in patients with definite non-ax-SpA mechanical chronic back pain. (2022) (1)
How to Define Remission and Low Disease Activity in Psoriatic Arthritis? an Analysis of 419 Patients with a Double Perspective, Based on Composite Scores and Patients' and Physicians' Perspectives (2018) (1)
POS1169 THE INFLAMMATION INDUCED BY MONOSODIUM URATE AND CALCIUM PYROPHOSPHATE CRYSTALS DEPENDS ON OSMOLARITY AND AQUAPORIN CHANNELS. (2022) (1)
FRI0314 Assessment of the Ultrasonography's Efficiency as a Diagnostic Tool for Calcium Pyrophosphate Crystal Deposition Disease (2015) (1)
Novel pathogenic variants in SLCO2A1 causing autosomal dominant primary hypertrophic osteoarthropathy. (2022) (1)
Decision algorithms for the re-treatment with viscosupplementation in patients suffering from knee osteoarthritis (2017) (1)
THU0401 Ultrasound evaluation in follow-up of urate-lowering therapy in gouty patients: the useful study (2017) (1)
THU0496 Combined Chondroitin Sulfate and Glucosamine is More Efficient than Celebrex in Reducing Serum Levels of COLL2-1, A Cartilage Degradation Biomarker, In Patients with Severe OA: Results from a Randomized, Double-Blind, Multicentric Clinical Trial (2015) (1)
Metacarpophalangeal Joint Impairment in Hand Osteoarthritis and Its Association With Mechanical Factors: Results From the Digital Cohort Osteoarthritis Design Hand Osteoarthritis Cohort (2021) (1)
FRI0235 Effect of serum uric acid (SUA) on gout flares (GF) and tophi resolution in gout patients. pooled post hoc analysis of clear 1 & clear 2 trials (2018) (1)
Sick leave in early axial spondyloarthritis: the role of clinical and socioeconomic factors. Five-year data from the DESIR cohort (2021) (1)
Chondrocalcinosis of the knee and the risk for knee or hip osteoarthritis progression: data from the Khoala cohort (2018) (1)
RECOMMENDATIONS FOR AN UPDATE OF THE CURRENT (2010) EUROPEAN REGULATORY GUIDELINE ON CLINICAL INVESTIGATION OF MEDICINAL PRODUCTS USED IN THE TREATMENT OF OSTEOARTHRITIS AND REFLECTIONS ABOUT RELATED CLINICALLY RELEVANT OUTCOMES (2015) (1)
OP0007 CCR2 inhibition abrogates IL-6–induced activation of matrix metalloproteinases in cartilage (2017) (1)
POS1035 UPADACITINIB AS MONOTHERAPY AND IN COMBINATION WITH NON-BIOLOGIC DMARDs FOR THE TREATMENT OF PSORIATIC ARTHRITIS: SUBGROUP ANALYSIS FROM TWO PHASE 3 TRIALS (2021) (1)
Arthropathies destructrices du sujet âgé (2004) (1)
THU0438 DO CORTICOSTEROIDS OR HYALURONIC ACID INTRA-ARTICULAR INJECTIONS IMPACT THE RISK OF TOTAL KNEE REPLACEMENT? REAL-LIFE DATA FROM THE KHOALA COHORT (2019) (1)
OP0018 A Randomized, Multicentre, Double Blind, Placebo Controlled Study of Anti Tnf Alpha (Adalimumab) in Refractory Hand Osteoarthritis (2013) (1)
Assessment of the synovial fluid interleukin-1 receptor antagonist (IL-1Ra)/interleukin-1 beta (IL-1beta) ratio in patients with osteoarthritis and rheumatoid arthritis. (2006) (1)
Defining remission in patients with gout (2019) (1)
Surveillance dermatologique dun patient trait par les molcules ciblant le TNF alpha (2011) (1)
Traitement par thiosulfate de sodium intraveineux pour les calcinoses liées aux connectivites : à propos de 4 cas (2017) (1)
Gène ANKH et chondrocalcinose articulaire familiale (2004) (1)
Orthèses de repos dans la rhizarthrose : résultats d'une étude multicentrique randomisée contrôlée (2007) (1)
Utilisation du fébuxostat chez les patients ayant un antécédent de réaction cutanée à l’allopurinol (2014) (1)
Marqueurs biochimiques du cartilage et de l'os (2004) (1)
Examen physique du genou non traumatique (2006) (1)
Efficacité d’upadacitinib chez des patients atteints de rhumatisme psoriasique en fonction du nombre de traitements de fond biologiques antérieurs (2020) (1)
Le paracétamol est-il un médicament anodin en rhumatologie ?☆ (2014) (1)
Impact de la COVID-19 sur les initiations et les renouvellements des biothérapies et traitements synthétiques ciblés en France (2020) (1)
Fréquence de l'arthrose généralisée (polyarthrose) dans une population de patients présentant une gonarthrose (2011) (1)
Efficacité de l’anakinra dans le traitement de l’arthrite réfractaire aiguë induite par cristaux de PPCa (2012) (1)
Le psoriasis est un facteur de sévérité chez les malades ayant des rachialgies inflammatoires récentes : données issues de la cohorte DESIR (2012) (1)
La densité minérale osseuse chez des patients ayant une coxarthrose commune ou une coxarthrose destructrice rapide est-elle différente?: résultats d'une étude prospective cas-contrôle (2006) (1)
Actualités des arthropathies microcristallines (2011) (1)
Weight Loss: Preventive and Therapeutic Effects in Obese Patients with Osteoarthritis (2012) (0)
Pain in women with knee and/or hip osteoarthritis is related to adipose tissue dysfunction - data from the khoala cohort (2021) (0)
Impact of COVID-19 on initiation of biologic therapy prescriptions for chronic inflammatory diseases (2021) (0)
THU0210 Impact of Components of the Metabolic Syndrome on Knee Osteoarthritis Progression in the SEKOIA Study (2014) (0)
Apport des recommandations internationales sur le traitement hypouricémiant de la goutte* (2022) (0)
P333 IS THE BONE MINERAL DENSITY DIFFERENT BETWEEN PATIENTS WITH RAPIDLY DESTRUCTIVE AND SLOWLY HIP OSTEOARTHRITIS (2006) (0)
SAT0412 DOES THERAPEUTIC EDUCATION IMPROVE GOUT MANAGEMENT: THE EXPERIENCE OF LARIBOISIERE UNIVERSITY HOSPITAL PARIS-FRANCE (2019) (0)
Metacarpophalangeal impairment in hand osteoarthritis is not rare and is associated with mechanical rather than systemic factors (2021) (0)
First national osteoarthritis patients’ survey in France: Patients insights first (2014) (0)
FRI0374 Factors associated with poor control of urate levels under urate lowering therapy: A cross sectional study of 1689 gouty patients (2013) (0)
398 SPLINT FOR BASE OF THUMB OSTEOARTHRITIS: A 12 MONTH RANDOMIZED CONTROLLED STUDY (2007) (0)
Retreatment with Hyaluronic Acid Viscosupplementation in Knee Osteoarthritis: Agreement between EUROVISCO Guidelines and Current Medical Practice (2021) (0)
POS1030 EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS STRATIFIED BY BASELINE SKIN SEVERITY: A SUBGROUP ANALYSIS OF TWO PHASE III TRIALS (2021) (0)
La structuromodulation : mise au point (2004) (0)
POS1236 IMPACT OF COVID-19 ON INITIATION AND RENEWAL OF BIOTHERAPIES AND TARGETED SYNTHETIC TREATMENTS (2021) (0)
AB0115 BFGF increases HES1 and HEY1 expressions in murine chondrocytes in vitro (2013) (0)
Impact of components of the metabolic syndrome on progression of knee osteoarthritis in the Sekoia study (2014) (0)
Uricaemia as a surrogate endpoint in gout trials and the treat-to-target approach for gout management (2021) (0)
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2015): ESCEO Symposia Abstracts (2015) (0)
THU0152 Who are the patients with rheumatoid arthritis (RA) who are getting comorbidity screening procedures in accordance with guidelines? a study of 769 established ra patients (2017) (0)
[Crystal arthropathies: what's new?]. (2011) (0)
Dose-responsive effects of estrogens on interleukin-1 beta induced metalloprotease gene expression and no production by articular chondrocytes. (2000) (0)
AB0642 Efficacy of anakinra in gouty arthritis in real life population: a report of 36 cases. (2013) (0)
Iconography : Achondroplasia: From genotype to phenotype (2008) (0)
New Insights on the Pathogenesis and Treatment of Crystal Arthritis (2013) (0)
SAT0553 Chondrocalcinosis of the knee and the risk for knee or hip osteoarthritis progression: data from the khoala cohort (2018) (0)
OP0278-PARE The french patient's association (AFLAR: french league against rheumatism) has generated the french national alliance against osteoarthritis and the first general convention of osteoarthritis in france: a campaign to create a national lobbying tool to improve the management of osteoarthr (2017) (0)
Proprotein convertase furin inhibits matrix metalloproteinase 13 in a TGFβ-dependent manner and limits osteoarthritis in mice (2018) (0)
Impact de la masse grasse sur la réponse thérapeutique aux anti-TNF et aux traitements conventionnels chez les patients atteints d’une spondylarthropathie axiale récente (2016) (0)
First national osteoarthritis patients survey in France: patients insights first! (2014) (0)
Arthrite septique de hanche avec abcès du psoas due à une salmonelle non typhique chez un sujet immunocompétent (2008) (0)
OP0066 IMPACT OF DIAGNOSIS AND TREATMENT OF TROPHERYMA WHIPPLEI INFECTION IN PATIENTS WITH PRE-EXISTING CHRONIC INFLAMMATORY RHEUMATIC DISEASES: DATA FROM THE NATIONAL Tw-IRD REGISTRY (2022) (0)
Association of Gout Polygenic Risk Score With Age at Disease Onset and Tophaceous Disease in European and Polynesian Men With Gout (2022) (0)
SAT0416 ULTRASOUND EVALUATION IN FOLLOW-UP OF URATE-LOWERING THERAPY IN GOUT PHASE 2 (USEFUL-2): DURATION OF FLARE PROPHYLAXIS (2019) (0)
OP0049 FACTORS ASSOCIATED WITH EARLY FLARES WHEN INITIATING URATE LOWERING THERAPIES. POST HOC ANALYSIS OF CLEAR 1,2 AND CRYSTAL TRIALS (2019) (0)
Identification of Symptoms Phenotypes of Hand Osteoarthritis using Hierarchical Clustering: Results from the DIGICOD Cohort. (2022) (0)
THU0396 Visceral Adipose Tissue and Cardiovascular Risk in Spondyloarthritis: Results from The DESIR and COMOSPA Cohorts (2016) (0)
OP0088 Inflammation on MRI of The Spine Is Longitudinally Related To Disease Activity in Smokers but Not in Non-Smokers in Axial Spondyloarthritis: 2-Year Data from The Desir Cohort (2016) (0)
AB1412 Nurses can achieve very good agreement with physicians for joint counts in rheumatoid arthritis – a feasible training method (2013) (0)
L’inflammation induite par les cristaux d’urate de sodium et de pyrophosphate de calcium est modulée par l’osmolarité et les aquaporines (2021) (0)
THU0461 Accuracy of humasens-plus point-of-care uric acid meter using capillary blood obtained by fingertip puncture (2017) (0)
FRI0434 Anterior chest wall pain in recent inflammatory back pain. data from the desir cohort. (2013) (0)
Clinically meaningful effect of strontium ranelate on knee osteoarthritis symptoms (2012) (0)
Patient Perception of Medical Care for Psoriatic Arthritis in North America and Europe: Results from a Global Patient Survey (2022) (0)
FRI0227 Risk factors for skin reactions to allopurinol in the kinh population of vietnam (2018) (0)
Early-onset gout and rare deficient variants of the lactate dehydrogenase D gene. (2023) (0)
POS1124 IDENTIFYING POTENTIAL CLASSIFICATION CRITERIA FOR CALCIUM PYROPHOSPHATE DEPOSITION DISEASE (CPPD): RESULTS FROM THE INITIAL PHASES (2021) (0)
Iconography : Obésité, hyperuricémie et goutte (2016) (0)
Analyse coût–utilité d’une prothèse totale de genou posée tôt versus tard pour les patients arthrosiques (2017) (0)
Identification of PsA phenotypes with machine learning analytics using data from two phase III clinical trials of guselkumab in a bio-naïve population of patients with PsA (2023) (0)
433 IMPROVEMENT OF THE REPRODUCIBILITY OF THE RADIOGRAPHIC KELLGREN-LAWRENCE (KL) SCORING SYSTEM IN HAND OSTEOARTHRITIS (HOA) USING A NEW KL SCORING SYSTEM AID (2010) (0)
POS0971 HOW DO CLINICAL AND SOCIOECONOMIC FACTORS IMPACT ON WORK DISABILITY IN EARLY AXIAL SPONDYLOARTHRITIS? FIVE-YEAR DATA FROM THE DESIR COHORT (2021) (0)
OP0259 MINIMAL DISEASE ACTIVITY RESPONSE PATTERNS IN BIO-NAIVE PATIENTS TREATED WITH GUSELKUMAB: A MACHINE LEARNING ANALYSIS (2022) (0)
I-17 METABOLIC DISEASES AND OA (2010) (0)
P180 Minimal disease activity response patterns in bio-naïve patients with psoriatic arthritis treated with guselkumab: a machine learning analysis (2023) (0)
' s response to reviews Title : Comparison of general practitioners and rheumatologists ' prescription patterns for patients with knee osteoarthritis (2011) (0)
Identification des patients avec psoriasis sous biothérapie ou traitement systémiques à partir des données de dispensation : étude de faisabilité et analyse de l’impact de la COVID-19 sur les prescriptions (2021) (0)
THU0422 CALCIUM PYROPHOSPHATE CRYSTAL DEPOSITION WITHIN TOPHUS LOBULE: A FREQUENT ASSOCIATION OBSERVED IN LONG-TIME COURSE TOPHI (2020) (0)
SAT0410 RADIOGRAPHIC EROSION SCORE IMPROVED WITH TARGETED URATE-LOWERING THERAPY IN A PROSPECTIVE GOUT VIETNAMESE COHORT (2019) (0)
AB0900 Serum uric acid level variations during gout attacks are linked neither to inflammation nor to uric acid fractional excretion: a prospective study of 35 patients (2017) (0)
THU0437 SPECIFIC COMORBIDITIES ENHANCE MONOSODIUM URATE CRYSTAL DEPOSITION IN GOUT: A MULTICENTRE DUAL-ENERGY COMPUTED TOMOGRAPHY STUDY (2020) (0)
FRI0395 Five phenotype profiles are revealed by cluster analysis in patients with gout. Results from a cohort of 2762 patients (2013) (0)
Simple Application and Adherence to Gout Guidelines Enables Disease Control: An Observational Study in French Referral Centres (2022) (0)
Le dépistage et la prévention des comorbidités dans la polyarthrite rhumatoïde (PR) après un programme d’information par infirmier : suivi à 3 ans de 769 patients atteints de PR établie de l’étude COMEDRA (2016) (0)
OP-BRHE170428 1..3 (2017) (0)
Identification de phénotypes symptomatiques d’arthrose digitale à partir d’une méthode de clustering hiérarchique : résultats de la cohorte DIGICOD (2021) (0)
SAT0257 Is hidradenitis suppurativa an extra articular feature of spondyloarthritis? Results from a multicentre national prospective study (2013) (0)
Scanner des sinus: un examen superflu, utile ou indispensable au "bilan" avant traitement par agent anti-TNF ? (2006) (0)
Can we identify patients to be treated in osteoarthritis (2015) (0)
National alliance against osteoarthritis: A French coalition to research and mobilize against osteoarthritis (2013) (0)
PARE0022 First National Osteoarthritis Patients Survey in France: Patients Insights First! (2014) (0)
I154 Better Understanding Co-Morbidity in Gout: Novel Disease Associations and Inter-Relationships (2016) (0)
FRI0182 Erosions at the sacroiliac joints and fatty lesions at the spine are the most discriminant lesions for recent onset axspa recognition (2018) (0)
FRI0348 PERSISTENCE OF SECUKINUMAB AND USTEKINUMAB IN PSORIATIC ARTHRITIS: A REAL-WORLD MULTICENTRIC COHORT OF 409 PATIENTS (2020) (0)
MRI Features Associated With the Detection of Microbial Pathogens by CT-Guided Biopsy in Septic Spondylodiscitis (2020) (0)
THU0526 Efficacy and Safety of Febuxostat in 73 Gouty Patients with Stage 4/5 Chronic Kidney Disease: Result from A Retrospective 9 Multicenter Study (2016) (0)
Inhibition of HMGA2 abolishes articular cartilage regeneration induced by Lin28a in mice (2020) (0)
Uricémie à l’objectif : le challenge des experts de la goutte, étude rétrospective sur 3 centres experts en France – étude Urate-Challenge (2021) (0)
POS0993 RADIOLOGICAL CERVICAL INVOLVMENT IN ANKYLOSING SPONDYLITIS (2022) (0)
Actualité de la génétique des chondrocalcinoses (2022) (0)
Lu.141Méthotrexate et les chondrocalcinoses réfractaires : à propos de trois cas (2007) (0)
INCREASES Hes 1 AND Hey 1 EXPRESSIONS IN MURINE CHONDROCYTES IN VITRO (2010) (0)
126 EFFECTS OF IRON DEPLETION ON ARTICULAR BIOMARKERS AND JOINT SYMPTOMS IN PATIENTS WITH GENETIC HEMOCHROMATOSIS: A PROSPECTIVE, LONGITUDINAL STUDY (2009) (0)
What is the role of the PRP (platelet-rich plasma) in tendinopathies? (2015) (0)
POS1161 CAN DOCTORS TREAT GOUT WELL? INSIGHT ON GOUT MANAGEMENT IN REFERRAL CENTRES (2022) (0)
POS1077 LARGE JOINT INVOLVEMENT AND SUBSTANTIAL DISEASE BURDEN IN PATIENTS WITH OLIGOARTICULAR AND POLYARTICULAR PSORIATIC ARTHRITIS IN THE MULTINATIONAL UPLIFT SURVEY (2022) (0)
A PPARalpha-dependent pathway increases IL-1ra production and protects from IL-1beta detrimental effects in articular chondrocytes (2004) (0)
Effects of iron depletion on articular biomarkers and joint symptoms in patients with genetic hemochromatosis: a prospective, longitudinal study. (2009) (0)
Induction of heme oxygenase-1 inhibits interleukin-1 beta-dependant nitrite oxide production in articular chondrocytes (2004) (0)
National Health and Nutrition Examination Survey, The (2020) (0)
The French Patient's Association (Aflar: French League Against Rheumatism) has Generated The French National Alliance Against Osteoarthritis and the First General Convention of Osteoarthritis in France: A Campaign to Create a National Lobbying Tool to Improve the Management of Osteoarthritis (2017) (0)
Correction to: Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects (2020) (0)
365 MANAGEMENT OF KNEE OSTEOARTHRITIS: COMPARISON OF GENERAL PRACTITIONERS AND RHEUMATOLOGISTS' PRACTICES (2009) (0)
POS0309 ARE PATIENTS’ AND RHEUMATOLOGISTS’ PERCEPTIONS OF THE BURDEN AND TREATMENT OF PSORIATIC ARTHRITIS ALIGNED? RESULTS FROM THE UPLIFT SURVEY (2022) (0)
POS1055 IDENTIFICATION OF PsA PHENOTYPES WITH MACHINE LEARNING ANALYTICS USING DATA FROM A PHASE 3 CLINICAL TRIAL PROGRAMME OF GUSELKUMAB IN A BIO-NAÏVE PATIENT POPULATION (2022) (0)
OA9 Aspects radiologiques de l’atteinte osteoarticulaire de la maladie de gaucher (2005) (0)
Prise en charge du syndrome du canal carpien: de l'échographie diagnostique à la libération percutanée sous échographie (2017) (0)
L’arthrose digitale en 2023 (2022) (0)
La main rhumatologique - Opus XVII (collection) (2015) (0)
Les lésions osseuses sous-chondrales dans l'arthrose (2003) (0)
Maintien des traitements hypouricémiants après initiation et impact sur le risque cardiovasculaire à 5 ans : étude sur la base de données LRx (2021) (0)
La cohorte DESIR : un suivi à dix ans des lombalgies inflammatoires récentes en France : méthodologie et caractéristiques initiales des 708 patients recrutés (2011) (0)
Qu'est-ce qui peut tomber à l'examen ? (2006) (0)
Iconographies supplémentaires de l'article : Manifestations cutanées paradoxales des anti-TNF-alpha (2010) (0)
Facteurs de risque de mortalité des pneumopathies interstitielles diffuses associées à la polyarthrite rhumatoïde (2022) (0)
Pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde : étude descriptive de 189 patients provenant de la cohorte française TRANSLATE (2016) (0)
Les traitements en cours de développement dans l’arthrose (2021) (0)
Erratum to "2022 French Society for Rheumatology (SFR) recommendations on the everyday management of patients with spondyloarthritis, including psoriatic arthritis" [Joint Bone Spine 2022;89:105344]. (2022) (0)
Obésité et gonarthrose. (2007) (0)
Impact de la COVID-19 sur l’initiation des prescriptions des biothérapies dans les maladies inflammatoires chroniques (2021) (0)
All that glistens is not gold. (2022) (0)
Les antiarthrosiques symptomatiques d'action lente (AASAL) (2008) (0)
Première enquête nationale Française « arthrose » : la parole aux patients ! (2014) (0)
Pratiques et croyances alimentaires des patients atteints de maladies rhumatismales et relation avec les symptômes : résultats d’une étude transversale multicentrique (2022) (0)
A New Look at an Old Procedure? (2022) (0)
Inhibition of Sphingosine 1 Phosphate produced by Osteoclasts reduces chondrocyte catabolism and prevents osteoarthritis in mice (2016) (0)
OP0243 SERPINA3N LIMITS CARTILAGE DESTRUCTION IN OSTEOARTHRITIS BY INHIBITING MACROPHAGE-DERIVED LEUKOCYTE ELASTASE (2020) (0)
Prévalence et conséquences du psoriasis sur les spondyloarthrites axiales récentes : une analyse de 589 patients sur 6 ans (2021) (0)
Implication des troubles métaboliques dans la progression radiologique de la gonarthrose : analyse post-hoc issue de l'essai randomisé SEKOIA (2014) (0)
Traitement d’une calcinose sous cutanée par injection intra lésionnelle de Thiosulfate de Sodium : à propos de 2 cas (2016) (0)
STRONTIUM RANELATE DECREASES THE NUMBER OF RAPID RADIOLOGICAL PROGRESSORS FROM THE FIRST YEAR IN SEKOIA STUDY (2014) (0)
Identification des maladies inflammatoires chroniques traitées en ville par biothérapie ou traitement synthétique ciblé (2020) (0)
Adhesive capsulitis of the shoulder: Diagnostic value of active and passive range of motion with volume of the gleno-humeral capsule as reference (2014) (0)
Le scorbut en rhumatologie (2003) (0)
Opérer les ménisques dégénératifs (2010) (0)
THU0271 Emergence of severe spondyloarthropathy related entheseal pathology following vedolizumab therapy for inflammatory bowel disease (2018) (0)
Traitements des formes inflammatoires chroniques de rhumatisme à cristaux de pyrophosphate de calcium (PPC) : une étude observationnelle européenne multicentrique (2022) (0)
Faut-il opérer les tophus des doigts? (2014) (0)
Traitement percutané du doigt à ressaut par section de la poulie A1 sous contrôle échographique (2020) (0)
Polyarthrite rhumatoïde : étude rétrospective de 234 patients ayant des ancêtres d’origine africaine ou caucasoïde (2016) (0)
Caractéristiques de l’atteinte cervicale radiographique des spondyloarthrites ankylosantes (2021) (0)
Identification de marqueurs associés à la présence d’une pneumopathie interstitielle diffuse chez les patients atteints d’une polyarthrite rhumatoïde (2016) (0)
Injections de Plasma Riche en Plaquettes dans la gonarthrose : recommandations pour la pratique clinique élaborées par un groupe d’experts internationaux (2019) (0)
Le jeûne intermittent réduit l’inflammation microcristalline (2022) (0)
Quelle place pour les PRP (plasma riche en plaquettes) dans les tendinopathies (2015) (0)
Hes1, nouveau gène cible d'IL1b dans les chondrocytes (2007) (0)
Time to Total Knee Arthroplasty after Intra-Articular Hyaluronic Acid or Platelet-Rich Plasma Injections: A Systematic Literature Review and Meta-Analysis (2022) (0)
Tryptophan Metabolites Are Associated With Erosion And Pain In Hand Osteoarthritis: Results From The Digicod Cohort (2023) (0)
23% de gonarthroses évitées en 5 ans, chez des personnes en surpoids ou obèses, perdant 5% à 9% de leur poids: un modèle mathématique (2016) (0)
Apparition de novo d'un rhumatisme psoriasique chez des patients traités par Efalizumab pour un psoriasis cutané : un effet secondaire inattendu d'une nouvelle biothérapie dans le psoriasis (2007) (0)
Statues, pathologies articulaires et osseuses (2005) (0)
ESTROGÈNES ET ARTHROSE (2008) (0)
Mise en évidence d’une nouvelle mutation en 5′UTR dans le gène ANKH à l’origine d’une chondrocalcinose articulaire familiale (2021) (0)
Actualités des chondrocalcinoses secondaires (2007) (0)
Étude observationnelle des symptômes de stress liés à l’épidémie de Covid-19 dans une cohorte de patients souffrant d’arthrose (2021) (0)
Le ranélate de strontium diminue la proportion de patients progressant rapidement dès la première année : une analyse post hoc de l'étude SEKOIA (2013) (0)
Persistance similaire sur 15 mois de l’ustékinumab (UST) et des anti-TNF chez les patients atteints de rhumatisme psoriasique (RP) : étude PsABio multicentrique en vraie vie (2020) (0)
L’atteinte des articulations métacarpophalangiennes est une localisation fréquente au cours de l’arthrose digitale : résultats de la cohorte DIGICOD (2020) (0)
Efficacité et tolérance à long terme de l’upadacitinib chez les patients présentant un rhumatisme psoriasique réfractaire aux traitements biologiques : résultats à 2 ans de l’étude de phase III SELECT-PsA 2 (2022) (0)
POS1165 ASSOCIATION OF LDHD RARE VARIANTS WITH EARLY-ONSET GOUT IN TWO FAMILIES WITH AN ADDITIONAL ASSOCIATION OF RHBG VARIANT IN ONE. (2022) (0)
Les antiarthrosiques symptomatiques lente (AASAL) (2008) (0)
Hidradénite suppurée sévère et dermatose neutrophilique, un nouveau syndrome auto-inflammatoire : quatre observations (2012) (0)
AB0882 Efficacy of intralesionnal sodium thiosulfate in disabling tumoral calcinosis: about two cases (2017) (0)
Lymphome sous méthotrexate dans la polyarthrite rhumatoïde: présentations atypiques (2006) (0)
Aponévrotomie percutanée itérative à l’aiguille pour maladie de Dupuytren : résultats fonctionnels à 5 ans (2020) (0)
Recommandations du groupe EUROVISCO pour le retraitement par acide hyaluronique des patients préalablement traités par viscosupplémentation pour une gonarthrose (2016) (0)
Prévalence et facteurs associés à la chondrocalcinose articulaire au cours de l’hémochromatose héréditaire de type HFE1 (2016) (0)
L’auto-évaluation de la maladie dans la polyarthrite rhumatoïde (PR) par l’auto-DAS28 est-elle acceptable au long cours ? Suivi à 3 ans d’un programme réalisé par des infirmiers (COMEDRA) chez 771 patients atteints de PR établie (2016) (0)
Critères diagnostiques de l’arthrose généralisée : étude préliminaire dans une population de gonarthrose (2011) (0)
P148 ESTROGENS INHIBIT INTERLEUKIN-1β-MEDIATED NITRIC OXIDE SYNTHASE EXPRESSION IN ARTICULAR CHONDROCYTES THROUGH NF-kB IMPAIRMENT (2006) (0)
OP0053 IMPACT OF CORRECTING CRP THRESHOLD ACCORDING TO BMI ON DIAGNOSIS, DISEASE ACTIVITY, INDICATION OF BIOLOGICAL TREATMENT AND PREDICTION OF THERAPEUTIC RESPONSE, IN PATIENTS SUSPECTED OF AXIAL SPONDYLOARTHRITIS. RESULTS FROM DESIR COHORT (2021) (0)
Combined Chondroitin Sulfate and Glucosamine Is Comparable to Celecoxib for Painful Knee Osteoarthritis. Results from a Multicenter, Randomized, Double-Blind, PHASE IV NON-Inferiority TRIAL. (2014) (0)
OP0298 ARE PATIENTS WITH PSORIATIC ARTHRITIS BEING TREATED OPTIMALLY ACROSS THE WORLD? DISPARITIES IN HEALTH CARE FOR PATIENTS WITH PSORIATIC ARTHRITIS ACROSS COUNTRIES WITH DIFFERENT GDP’S, AN ANALYSIS OF 429 PATIENTS FROM 13 COUNTRIES (2021) (0)
Obésité et pathologies rhumatologiques (2016) (0)
Définitions quantifiables des recommandations de prise en charge de la spondylarthrite ankylosante sont nécessaires pour leur utilisation dans des études observationnelles (2016) (0)
Syndromes PAPASH, PsAPASH et PASS : hétérogénéité phénotypique, signature biologique commune, intérêt des thérapeutiques immunosuppressives (2018) (0)
Facteurs associés aux formes sévères de spondyloarthropathie axiale : résultats de l’étude nationale multicentrique Bamboospine (2016) (0)
Y a-t-il deux rhumatismes psoriasiques ? Profils et prise en charge des patients initiant un traitement par ustekinumab chez le dermatologue ou le rhumatologue : étude en vraie vie PROUST (2020) (0)
La colchicine à faible dose pour le traitement de l'accès aigu goutteux: efficace et bien tolérée (2009) (0)
250 bFGF INCREASES Hes1 AND Hey1 EXPRESSIONS IN MURINE CHONDROCYTES IN VITRO (2010) (0)
Association entre les métabolites du tryptophane et la présence d’érosions et de symptômes dans l’arthrose digitale : résultats issus de la cohorte DIGICOD (2022) (0)
FRI0369 Health Utilities and Costs Among Early Spondyloarthritis Patients Treated and not Treated with TNFα Blockers: Estimates from the Desir Cohort (2015) (0)
Impact du traitement par statines dans la progression radiologique de la gonarthrose : résultats issus de l’analyse post-hoc de l’essai SEKOIA (2019) (0)
Excès de variants rares délétères au sein de gènes appartenant à la voir JAK-STAT chez des patients atteints de pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde (2022) (0)
Comparaison de l’efficacité de l’ustékinumab (UST) ou des anti-TNFa chez des patients atteints de rhumatisme psoriasique (RP) dans l’étude multipays en vraie vie PsABio: suivi à 12 mois (2020) (0)
Les patients atteints de rhumatisme psoriasique sont-ils traités de manière optimale autour du monde ? Disparités entre pays dans le rhumatisme psoriasique : une analyse de 410 patients provenant de 13 pays (2021) (0)
534 EFFECTS OF INTRA-ARTICULAR INJECTIONS OF HYLAN GF-20 ON SERUM AND URINE BIOMARKERS IN PATIENTS WITH KNEE OSTEOARTHRITIS: THE BIOVISCO STUDY (2010) (0)
Effets anti-interleukine 1β in vitro des œstrogènes et de la rosiglitazone dans les chondrocytes articulaires : analyse des mécanismes d'action moléculaires (2003) (0)
Compléments : Obésité, hyperuricémie et goutte (2016) (0)
Iconographies supplémentaires de l'article : Traitement par thiosulfate de sodium intraveineux pour les calcinoses liées aux connectivites : à propos de 4 cas (2017) (0)
Déficit en D-lactate déshydrogénase d’origine génétique : une cause nouvelle de goutte juvénile enzymopathique (2022) (0)
Evaluation de la fiabilité du système HumaSens-plus mesurant l’acide urique sur sang capillaire (2016) (0)
Cholangite neutrophilique et psoriasis (2012) (0)
Facteurs de pronostic de la coxarthrose (2009) (0)
Iconography : Nouveaux traitements de la goutte (2011) (0)
Efficacy and Safety of Febuxostat in 55 Gouty Patients with Stage 4/5 Chronic Kidney Disease: Results from a Retrospective Multicenter Study (2015) (0)
L'interleukine 1 beta diminue la présence et la fonctionnalité du récepteur aux estrogènes dans les chondrocytes (2006) (0)
Efficacité et sécurité de l’anakinra dans la goutte associée à une insuffisance rénale chronique de stade 4 ou 5 ou à une transplantation rénale : étude rétrospective multicentrique (2019) (0)
Efficacité et tolérance du fébuxostat chez 73 patients goutteux avec une insuffisance rénale chronique stade 4/5 : étude rétrospective de 10 centres (2017) (0)
Rôle des chémokines CCL-7 et CCL-8 dans l’arthrose (2016) (0)
DIGICOD, cohorte prospective observationnelle hospitalière de patients souffrant d’arthrose digitale : méthodologie et caractéristiques de la population d’inclusion (2022) (0)
Alliance nationale contre l’arthrose : groupe français de réflexion et de mobilisation sur les enjeux de l’arthrose (2013) (0)
Faut-il conserver une place à l’acide hyaluronique dans le traitement de la gonarthrose ? ☆ (2017) (0)
L'achondrodysplasie en 2002 (2002) (0)
Hidradénite suppurée et rhumatisme inflammatoire : étude prospective multicentrique (2012) (0)
Complications articulaires et osseuses de l’hémochromatose génétique : résultats d’une étude cas-contrôle sur 609 patients (2012) (0)
Nouveaux traitements de la goutte : Arthropathies microcristallines. (2011) (0)
Traitement du doigt à ressaut par section de la poulie A1 à l’aiguille sous contrôle échographique : étude observationnelle prospective (2022) (0)
Élaboration et passation en population générale d’un questionnaire visant à estimer la prévalence de la goutte en France (2016) (0)
Impact du traitement d’une infection à Tropheryma whipplei chez des patients atteints d’un rhumatisme inflammatoire chronique traités par DMARD : données du registre national WHIRIC (2021) (0)
Dépôts de cristaux de pyrophosphate de calcium au sein des tophus goutteux (2020) (0)
Actualisation 2022 des Recommandations de la Société Française de Rhumatologie (SFR) pour la prise en charge en pratique courante des malades atteints de spondyloarthrite, incluant le rhumatisme psoriasique (2022) (0)
Capsulite rétractile de l’épaule : valeur diagnostique de l’examen clinique de la mobilité active et passive avec pour référence le volume capsulaire gléno-huméral (2014) (0)
Upadacitinib en monothérapie et en association avec des DMARDs non biologiques pour le traitement du rhumatisme psoriasique : analyse en sous-groupes de deux essais de phase 3 (2020) (0)
Forage et greffes cervicocéphaliques dans la nécrose de la tête fémorale : état des lieux (2011) (0)
Serum Tryptophan Metabolites are Associated with Erosive Hand Osteoarthritis and Pain: Results from the DIGICOD Cohort. (2023) (0)
Intérêt de l’application d’une contention élastique adhésive dans l’arthrose des membres inférieurs. Élaboration de recommandations françaises pour la pratique clinique (2008) (0)
P168 INCREASED AGGREGATION OF PROTEOGLYCAN COMPLEXES BY CHONDROITIN SULFATES ADDED TO IL-1 TREATED CHONDROCYTES IS ASSOCIATED WITH DECREASED ADAMTS-5 EXPRESSION (2006) (0)
Association pseudo-xanthome élastique et polyarthrite rhumatoïde : à propos de trois cas (2001) (0)
Colchicine ou Prednisone pour la crise à cristaux de pyrophosphate de calcium ? Résultats de l’Étude Randomisée Multicentrique COLCHICORT (2022) (0)
Intérêt de l’IRM et de l’échographie dans la détection de l’arthrose interphalangienne précoce (2022) (0)
Maladie de Verneuil : aux confins des spondyloarthrites (2015) (0)
Y a-t-il des traitements chondroprotecteurs ? (2001) (0)
La dysfonction du tissu adipeux associée à l’obésité viscérale et l’inflammation systémique sont associées à l’intensité de la douleur chez les femmes souffrant de gonarthrose et/ou coxarthrose : résultats de la cohorte KHOALA (2020) (0)
Les sulphates de chondroitine modulent la dégradation des protéoglycanes et l'expression d'ADAMTS-5 dans les chondrocytes traités par IL-1 (2007) (0)
L’inflammation induite par les cristaux d’urate de sodium et de pyrophosphate de calcium est modulée par le canal anionique LRRC8A (2022) (0)
Douleurs lombosciatiques révélatrices d'hémorragies méningées (1998) (0)
Fond génétique partagé entre la pneumopathie interstitielle diffuse associée à la polyarthrite rhumatoïde et la fibrose pulmonaire idiopathique (2016) (0)
Real-world evidence of the use of the infliximab biosimilar SB2: data from the PERFUSE study (2023) (0)
Hidradenitis suppurativa: A new disease related to spondyloarthritis (2015) (0)
Iconographies supplémentaires de l'article : Obésité, hyperuricémie et goutte (2016) (0)
SAT0389 Mri predictive factors for positive ct-guided biopsy in suspected septic spondylodiscitis (2018) (0)
RETRACTED: Quelle place pour les plasma riche en plaquettes (PRP) dans les tendinopathies ? (2014) (0)
Améliorer le consensus autour de l’évaluation de la synovite dans la polyarthrite rhumatoïde (2013) (0)
Eosinopenia to differentiate crystal-induced and septic arthritis (2022) (0)
Training on Skin Cancer Diagnosis in Rheumatologists : Results from a Nationwide Randomized Web-Based Survey (2019) (0)
La surexpression de Lin28a induit la reprogrammation chondrocytaire via l’axe Let-7/Hmga2 permettant un effet protecteur du cartilage au cours de l’arthrose chez la souris (2022) (0)
Sphingosine 1 phosphate produced by osteoclasts promotes chondrocyte catabolism (2016) (0)
Traitements symptomatiques et locaux dans le rhumatisme psoriasique (2020) (0)
Un tiers des patients atteints de polyarthrite rhumatoïde (PR) établie sont correctement vaccinés contre la grippe et le pneumocoque et cette proportion augmente : évaluation longitudinale sur 3 ans des 769 patients de l’étude COMEDRA (2016) (0)
Review Serum uric acid and metabolic risk (2013) (0)
262: Use of allopurinol and risk of myocardial infarction: A case-control study (2013) (0)
SAT0341 Strontium Ranelate Improves Osteoarthritis Symptoms Compared to Placebo in Patients with Knee OA - The Sekoia Study (2013) (0)
Disparities in healthcare in psoriatic arthritis: an analysis of 439 patients from 13 countries (2022) (0)
High synovial fluid interleukin-1 receptor antagonist (IL-1 RA)/interleukin-1 beta (IL-1beta) ratio naturally occurs in human knee osteoarthritis (2006) (0)
SAT0360 HFE C282Y/H63D Compound Heterozygotes are at Lower Risk of Hemochromatosis-Related Arthropathy (2013) (0)
[National ranking examination N16. What could fall at the exam?]. (2006) (0)
POS1032 EFFICACY OF UPADACITINIB IN PATIENTS WITH PSORIATIC ARTHRITIS STRATIFIED BY NUMBER OF PRIOR BIOLOGIC DISEASE-MODIFYING ANTI-RHEUMATIC DRUGS (2021) (0)
THU0106 Identification of Markers Associated with The Occurrence of Interstitial Lung Disease in Rheumatoid Arthritis Patients (2016) (0)
MRI and ultrasonography could be useful to detect early interphalangeal osteoarthritis. (2022) (0)
SAT0584 Impact of an Online Training on Skin Cancer Diagnosing in Rheumatologists, A Nationwide Randomized Web-Based Survey (2014) (0)
Retraitement par viscosupplémentation des patients souffrant de gonarthrose : la pratique médicale est cohérente avec les recommandations EUROVISCO (2020) (0)
Digicod, a large hospital-based observational prospective cohort of patients with hand osteoarthritis – baseline characteristics description (2021) (0)
Strontium ranelate increases the number of patients with improvement in osteoarthritis symptoms compared to placebo in the SEKOIA study (2013) (0)
Treatment of gout: where are we now? (2018) (0)
SAT0514 Does Hyperuricemia Worsen Pain and Function in Patients with Knee or Hip OA? Results from the Khoala Cohort (2014) (0)
SERPINA3N limits cartilage destruction in osteoarthritis by inhibiting macrophage-derived leukocyte elastase (2020) (0)
SAT0338 Tolerance and efficacy of a new formulation of diacerein: Results of a multicenter, randomized, double-blind, controlled trial in patients with knee osteoarthritis (2013) (0)
AB0862 CONSENSUS STATEMENT ON INTRA-ARTICULAR INJECTIONS OF PLATELET-RICH PLASMA FOR THE MANAGEMENT OF KNEE OSTEOARTHRITIS (2020) (0)
Efficacité d’upadacitinib chez des patients atteints de rhumatisme psoriasique stratifiés selon la sévérité de l’atteinte cutanée à l’inclusion : analyse en sous-groupes de deux études de phase III (2021) (0)
IDENTIFICATION OF CLINICAL PHENOTYPES OF HAND OSTEOARTHRITIS USING HIERARCHICAL CLUSTERING METHOD: RESULTS FROM THE DIGICOD COHORT (2022) (0)
POS1237 ALGORITHM IDENTIFYING CHRONIC INFLAMMATORY DISEASES TREATED BY BIOTHERAPY AND/OR TARGETED SYNTHETIC TREATMENTS IN OUTPATIENT CARE IN FRANCE: FEASIBILITY, PRELIMINARY RESULTS, AND IMPACT OF COVID-19 (2021) (0)
Le nouveau marqueur sérique du remodelage de la synoviale, Col 3-4, prédit le risque de progression radiologique dans la polyarthrite rhumatoïde débutante indépendamment des facteurs de risque classiques : l’étude ESPOIR (2022) (0)
OP0300 5-YEAR TRAJECTORIES OF URATE-LOWERING THERAPY AND IMPACT OF COLCHICINE ON CARDIOVASCULAR RISK: REAL-LIFE DATA ON 70,000+ PATIENTS (2022) (0)
SAT0112 Prevalence and incidence over 3 years of different comorbidities in rheumatoid arthritis (RA): a 3 year longitudinal study in 769 established ra patients (2017) (0)
Evidence that rosiglitazone acts as an antidegradative agent on cartilage cells in vitro (2003) (0)
La main rhumatologique - Opus XVIII (2017) (0)
THU0369 Costs of Early Spondyloarthritis: Estimates from the First Three Years of the Desir Cohort (2015) (0)
SAT0424 PHENOTYPE OF PATIENTS WITH EARLY ONSET GOUT (2019) (0)
Management of Peripheral Arthritis in Patients With Psoriatic Arthritis: An Updated Literature Review Informing the 2021 GRAPPA Treatment Recommendations (2022) (0)
Blockage of sphingosin 1 phosphate S1P/S1PR pathway prevents from osteoarthritis in mice by reducing chondrocyte catabolism (2018) (0)
EUROVISCO Good Practice Recommendations for a First Viscosupplementation in Patients with Knee Osteoarthritis. (2022) (0)
Allopurinol and risk of myocardial infarction (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Pascal Richette?

Pascal Richette is affiliated with the following schools:

Université Paris Cité
Paris Diderot University